Developing Robust AI Applications for Clinical Use: The Special Case of Pathology
Trillium Pathology · 2024
DOI: 10.47184/tp.2024.01.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trillium Pathology, 2024. Verfasst von Marc Aubreville. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Robustness is a key requirement for any method in medicine, especially when the method in question is being used as part of a diagnostic process. This is particularly true for artificial intelligence-based decision support systems, which, although being used as a supportive tool, will ultimately influence diagnostic assessments. In pathology, attaining clinical robustness in AI methods poses a particularly challenging task, primarily due to the extensive diversity of digital images, which humans can adapt to far more easily. This paper presents factors that contribute to this challenge, but also identifies and evaluates common solutions to counteract domain shift, which is known to deteriorate the performance of artificial intelligence models.
Zitieren
APA
Aubreville, M. (2024). Developing Robust AI Applications for Clinical Use: The Special Case of Pathology. Trillium Pathology. https://doi.org/10.47184/tp.2024.01.04
Vancouver
Aubreville M. Developing Robust AI Applications for Clinical Use: The Special Case of Pathology. Trillium Pathology. 2024. doi:10.47184/tp.2024.01.04
BibTeX
@article{Aubreville2024,
author = {Aubreville, Marc},
title = {Developing Robust AI Applications for Clinical Use: The Special Case of Pathology},
journal = {Trillium Pathology},
year = {2024},
doi = {10.47184/tp.2024.01.04}
}
EUVIMED